Jazz Pharmaceuticals plc Increase (Decrease) in Other Noncurrent Assets
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Other Noncurrent Assets of -$18.02 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2025-11-05
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$18.82M, a 589.57% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $50.00K, a 96.89% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $752.00K, a 81.61% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was $40.28M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for fiscal 2024 was $49.82M, a 213.65% increase from fiscal 2023.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for fiscal 2023 was $15.88M, a 33.92% decline from fiscal 2022.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for fiscal 2022 was $24.04M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent assets for fiscal 2021 was -$817.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$18.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$18.77M derived: sum of 2 quarters · filed 2025-11-05 | -$18.02M 10-Q · filed 2025-11-05 | $22.25M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2025-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $802.00K 10-Q · filed 2025-08-06 | $41.08M derived: sum of 3 quarters · filed 2025-08-06 | $44.92M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2025-03-31 | $752.00K 10-Q · filed 2025-05-07 | $41.03M derived: sum of 2 quarters · filed 2025-05-07 | $44.87M derived: sum of 3 quarters · filed 2025-11-05 | $46.48M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-12-31 | $40.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $44.12M derived: sum of 2 quarters · filed 2025-11-05 | $45.73M derived: sum of 3 quarters · filed 2025-11-05 | $49.82M 10-K · filed 2025-02-26 | ||||
| 2024-09-30 | $3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.45M derived: sum of 2 quarters · filed 2025-11-05 | $9.54M 10-Q · filed 2025-11-05 | $4.55M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $5.70M 10-Q · filed 2025-08-06 | $702.00K derived: sum of 3 quarters · filed 2025-08-06 | $8.68M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $4.09M 10-Q · filed 2025-05-07 | -$907.00K derived: sum of 2 quarters · filed 2025-05-07 | $7.07M derived: sum of 3 quarters · filed 2025-05-07 | $10.43M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.98M derived: sum of 2 quarters · filed 2025-02-26 | $6.34M derived: sum of 3 quarters · filed 2025-02-26 | $15.88M 10-K · filed 2025-02-26 | ||||
| 2023-09-30 | $7.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.34M derived: sum of 2 quarters · filed 2024-11-07 | $20.88M 10-Q · filed 2024-11-07 | $40.91M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $12.91M 10-Q · filed 2024-08-01 | $32.94M derived: sum of 3 quarters · filed 2025-02-26 | $36.62M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $9.54M 10-Q · filed 2024-05-02 | $29.57M derived: sum of 2 quarters · filed 2025-02-26 | $33.25M derived: sum of 3 quarters · filed 2025-02-26 | $34.56M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $20.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $23.71M derived: sum of 2 quarters · filed 2025-02-26 | $25.02M derived: sum of 3 quarters · filed 2025-02-26 | $24.04M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $4.99M derived: sum of 2 quarters · filed 2023-11-08 | $4.01M 10-Q · filed 2023-11-08 | $1.35M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $329.00K 10-Q · filed 2023-08-09 | -$2.33M derived: sum of 3 quarters · filed 2024-02-28 | -$661.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$979.00K 10-Q · filed 2023-05-10 | -$3.63M derived: sum of 2 quarters · filed 2024-02-28 | -$1.97M derived: sum of 3 quarters · filed 2024-02-28 | -$1.64M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$990.00K derived: sum of 2 quarters · filed 2024-02-28 | -$660.00K derived: sum of 3 quarters · filed 2024-02-28 | -$817.00K 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.99M derived: sum of 2 quarters · filed 2022-11-09 | $1.84M 10-Q · filed 2022-11-09 | -$6.13M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $330.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $173.00K 10-Q · filed 2022-08-03 | -$7.80M derived: sum of 3 quarters · filed 2023-03-01 | -$19.76M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$157.00K 10-Q · filed 2022-05-04 | -$8.13M derived: sum of 2 quarters · filed 2023-03-01 | -$20.09M derived: sum of 3 quarters · filed 2023-03-01 | -$21.57M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | -$7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$19.93M derived: sum of 2 quarters · filed 2023-03-01 | -$21.41M derived: sum of 3 quarters · filed 2023-03-01 | -$21.91M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | -$11.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$13.44M derived: sum of 2 quarters · filed 2021-11-09 | -$13.94M 10-Q · filed 2021-11-09 | $4.44M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$1.98M 10-Q · filed 2021-08-03 | $16.40M derived: sum of 3 quarters · filed 2022-03-01 | $15.87M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$505.00K 10-Q · filed 2021-05-04 | -$323.00K 10-Q · filed 2020-05-05 | $17.87M derived: sum of 2 quarters · filed 2022-03-01 | $17.35M derived: sum of 3 quarters · filed 2022-03-01 | $18.84M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $18.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.85M derived: sum of 2 quarters · filed 2022-03-01 | $19.34M derived: sum of 3 quarters · filed 2022-03-01 | $18.92M 10-K · filed 2022-03-01 | $14.83M 10-K · filed 2020-02-25 | |||
| 2019-09-30 | -$527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $966.00K derived: sum of 2 quarters · filed 2020-11-02 | $540.00K 10-Q · filed 2020-11-02 | -$2.25M 10-Q · filed 2019-11-05 | $2.82M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.07M 10-Q · filed 2020-08-04 | -$694.00K 10-Q · filed 2019-08-06 | $3.35M derived: sum of 3 quarters · filed 2021-02-23 | $5.36M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-03-31 | -$426.00K 10-Q · filed 2020-05-05 | $1.85M derived: sum of 2 quarters · filed 2021-02-23 | $3.86M derived: sum of 3 quarters · filed 2021-02-23 | $3.11M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $4.29M derived: sum of 2 quarters · filed 2021-02-23 | $3.54M derived: sum of 3 quarters · filed 2021-02-23 | $2.52M 10-K · filed 2021-02-23 | $320.00K 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.26M derived: sum of 2 quarters · filed 2019-11-05 | $244.00K 10-Q · filed 2019-11-05 | $6.49M 10-Q · filed 2018-11-06 | -$1.70M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | -$755.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$1.77M 10-Q · filed 2019-08-06 | $3.58M 10-Q · filed 2018-08-07 | -$3.71M derived: sum of 3 quarters · filed 2020-02-25 | -$4.15M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$1.01M 10-Q · filed 2019-05-07 | $3.99M 10-Q · filed 2018-05-08 | -$2.96M derived: sum of 2 quarters · filed 2020-02-25 | -$3.40M derived: sum of 3 quarters · filed 2020-02-25 | -$3.30M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.39M derived: sum of 2 quarters · filed 2020-02-25 | -$2.29M derived: sum of 3 quarters · filed 2020-02-25 | -$119.00K 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$345.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.82M 10-Q · filed 2018-11-06 | $1.85M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.27M 10-Q · filed 2018-08-07 | $2.30M derived: sum of 3 quarters · filed 2019-02-26 | $1.75M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $2.17M 10-Q · filed 2018-05-08 | $2.20M derived: sum of 2 quarters · filed 2019-02-26 | $1.66M derived: sum of 3 quarters · filed 2019-02-26 | $2.01M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$514.00K derived: sum of 2 quarters · filed 2019-02-26 | -$163.00K derived: sum of 3 quarters · filed 2019-02-26 | -$267.00K 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$193.00K derived: sum of 2 quarters · filed 2017-11-07 | -$297.00K 10-Q · filed 2017-11-07 | $4.92M 10-Q · filed 2016-11-08 | -$5.28M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $351.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $247.00K 10-Q · filed 2017-08-08 | $4.40M 10-Q · filed 2016-08-09 | -$4.74M derived: sum of 3 quarters · filed 2018-02-27 | -$1.84M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | -$104.00K 10-Q · filed 2017-05-09 | $1.99M 10-Q · filed 2016-05-10 | -$5.09M derived: sum of 2 quarters · filed 2018-02-27 | -$2.19M derived: sum of 3 quarters · filed 2018-02-27 | $1.19M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$2.08M derived: sum of 2 quarters · filed 2018-02-27 | $1.29M derived: sum of 3 quarters · filed 2018-02-27 | $4.57M 10-K · filed 2018-02-27 | $11.72M 10-K · filed 2016-02-23 | |||
| 2015-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $6.28M derived: sum of 2 quarters · filed 2016-11-08 | $9.55M 10-Q · filed 2016-11-08 | $6.84M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $6.66M 10-Q · filed 2016-08-09 | $3.94M derived: sum of 3 quarters · filed 2017-02-28 | $6.35M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $3.28M 10-Q · filed 2016-05-10 | $563.00K derived: sum of 2 quarters · filed 2017-02-28 | $2.97M derived: sum of 3 quarters · filed 2017-02-28 | $4.79M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$305.00K derived: sum of 2 quarters · filed 2017-02-28 | $1.51M derived: sum of 3 quarters · filed 2017-02-28 | $3.06M 10-K · filed 2017-02-28 | $8.89M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.23M derived: sum of 2 quarters · filed 2015-11-09 | $5.78M 10-Q · filed 2015-11-09 | $6.66M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.37M 10-Q · filed 2015-08-05 | $4.25M derived: sum of 3 quarters · filed 2016-02-23 | $5.05M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $1.54M 10-Q · filed 2015-05-07 | $2.43M derived: sum of 2 quarters · filed 2016-02-23 | $3.23M derived: sum of 3 quarters · filed 2016-02-23 | |||||
| 2013-12-31 | $885.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $1.69M derived: sum of 2 quarters · filed 2016-02-23 | $4.31M 10-K · filed 2016-02-23 | |||||
| 2013-09-30 | $804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $3.42M 10-Q · filed 2014-11-04 | ||||||
| 2013-06-30 | $2.62M 10-Q · filed 2014-08-05 | |||||||
| 2012-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $3.49M 10-K · filed 2015-02-24 | ||||||
| 2012-09-30 | $2.30M 10-Q · filed 2012-11-09 | |||||||
| 2011-09-30 | -$190.00K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |